In Nov. 2022, the U.S. nonprofit Multidisciplinary Affiliation for Psychedelic scientific studies (MAPS) introduced that it had concluded a second phase-a few trial on MDMA like a treatment method for PTSD—a stage https://janezqkb868106.wikiannouncement.com/user